Congestion game scheduling for virtual drug screening optimization

被引:0
作者
Natalia Nikitina
Evgeny Ivashko
Andrei Tchernykh
机构
[1] Russian Academy of Sciences,Institute of Applied Mathematical Research, Karelian Research Center
[2] CICESE Research Center,Computer Science Department
来源
Journal of Computer-Aided Molecular Design | 2018年 / 32卷
关键词
Drug discovery; Virtual drug screening; High-performance computing; High-throughput computing; Desktop grid; Game theory; Congestion game;
D O I
暂无
中图分类号
学科分类号
摘要
In virtual drug screening, the chemical diversity of hits is an important factor, along with their predicted activity. Moreover, interim results are of interest for directing the further research, and their diversity is also desirable. In this paper, we consider a problem of obtaining a diverse set of virtual screening hits in a short time. To this end, we propose a mathematical model of task scheduling for virtual drug screening in high-performance computational systems as a congestion game between computational nodes to find the equilibrium solutions for best balancing the number of interim hits with their chemical diversity. The model considers the heterogeneous environment with workload uncertainty, processing time uncertainty, and limited knowledge about the input dataset structure. We perform computational experiments and evaluate the performance of the developed approach considering organic molecules database GDB-9. The used set of molecules is rich enough to demonstrate the feasibility and practicability of proposed solutions. We compare the algorithm with two known heuristics used in practice and observe that game-based scheduling outperforms them by the hit discovery rate and chemical diversity at earlier steps. Based on these results, we use a social utility metric for assessing the efficiency of our equilibrium solutions and show that they reach greatest values.
引用
收藏
页码:363 / 374
页数:11
相关论文
共 44 条
[1]  
Bleicher K(2003)Hit and lead generation: beyond high-throughput screening Nat Rev Drug Discov 2 369-378
[2]  
Bielska E(2011)Virtual screening strategies in drug design—methods and applications BioTechnol 92 249-264
[3]  
Sosič I(2016)Nonpeptidic selective inhibitors of the chymotrypsin-like (β5 i) subunit of the immunoproteasome Angew Chem Int Ed 55 5745-5748
[4]  
Cavasotto CN(2015)Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models Chem Commun 51 13576-13594
[5]  
Palomba D(2011)A natural product-like inhibitor of NEDD8-activating enzyme Chem Commun 47 2511-2513
[6]  
Leung CH(1996)The art and practice of structure-based drug design: a molecular modeling perspective Med Res Rev 16 3-50
[7]  
Bohacek RS(2012)ZINC: a fee tool to discover chemistry for biology J Chem Inf Model 52 1757-1768
[8]  
McMartin C(2014)The ChEMBL bioactivity database: an update Nucleic Acids Res 42 1083-1090
[9]  
Guida WC(2010)ChemSpider: an online chemical information resource J Chem Educ 87 1123-1124
[10]  
Irwin J(2012)Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17 J Chem Inf Model 52 2864-2875